S. Cetin And I. Dede, "Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer," Journal of Cancer Research and Therapeutics , vol.16, no.4, pp.909-916, 2020
Cetin, S. And Dede, I. 2020. Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer. Journal of Cancer Research and Therapeutics , vol.16, no.4 , 909-916.
Cetin, S., & Dede, I., (2020). Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer. Journal of Cancer Research and Therapeutics , vol.16, no.4, 909-916.
Cetin, Sirin, And Isa Dede. "Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer," Journal of Cancer Research and Therapeutics , vol.16, no.4, 909-916, 2020
Cetin, Sirin And Dede, Isa. "Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer." Journal of Cancer Research and Therapeutics , vol.16, no.4, pp.909-916, 2020
Cetin, S. And Dede, I. (2020) . "Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer." Journal of Cancer Research and Therapeutics , vol.16, no.4, pp.909-916.
@article{article, author={Sirin Cetin And author={Isa Dede}, title={Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer}, journal={Journal of Cancer Research and Therapeutics}, year=2020, pages={909-916} }